| Literature DB >> 32455794 |
Giorgia Del Favero1,2, Annette Kraegeloh3.
Abstract
Integration of biophysical stimulation in test systems is established in diverse branches of biomedical sciences including toxicology. This is largely motivated by the need to create novel experimental setups capable of reproducing more closely in vivo physiological conditions. Indeed, we face the need to increase predictive power and experimental output, albeit reducing the use of animals in toxicity testing. In vivo, mechanical stimulation is essential for cellular homeostasis. In vitro, diverse strategies can be used to model this crucial component. The compliance of the extracellular matrix can be tuned by modifying the stiffness or through the deformation of substrates hosting the cells via static or dynamic strain. Moreover, cells can be cultivated under shear stress deriving from the movement of the extracellular fluids. In turn, introduction of physical cues in the cell culture environment modulates differentiation, functional properties, and metabolic competence, thus influencing cellular capability to cope with toxic insults. This review summarizes the state of the art of integration of biophysical stimuli in model systems for toxicity testing, discusses future challenges, and provides perspectives for the further advancement of in vitro cytotoxicity studies.Entities:
Keywords: cytotoxicity; matrix stiffness/deformation; mechanotransduction; shear stress
Mesh:
Year: 2020 PMID: 32455794 PMCID: PMC7290780 DOI: 10.3390/cells9051282
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1(A). Representative morphological adaptation resulting from the coexistence of cells in a multicellular organism. (B). Schematic representation of the procedures used to mimic cell deformation in vitro.
Overview of publications describing a modulatory role of stiffness on cell responses to chemical stimulation and diverse substrate stiffness. (RGD refers to the functionalization with arginine-glycine-aspartic acid; polyacrylamide is abbreviated as PA or PAA, polyethylene glycol as PEG)
| Physical Stimulation Stiffness | Chemical | Cell Model | Response | Reference |
|---|---|---|---|---|
| Collagen Type I or alginate | Doxorubicin, 5-Fluorouracil, Tamoxifen | Hepatocellular carcinoma Hep3B and Breast adenocarcinoma MCF-7 | No major difference between normal 96-well plates and 3D. Tendency toward increased resistance in the 3D structures. | [ |
| PEG + | Paclitaxel | human epithelial ovarian cancer cell line OV-MZ-6 and ovarian serous adenocarcinoma cell line SKOV-3 | Shape and size of spheroids dependent on the matrix (> Stiffness > compactness and < size). RDG-enhanced proliferation. 3D culture decreased sensitivity to drug. | [ |
| Alginate hydrogels | Acetaminophen, Diclofenac | Hepatocellular carcinoma HepG2 and Breast adenocarcinoma MCF-7 | [ | |
| Collagen-coated glass | Multiple chemicals | 12 cell types: 16HBE14o- | [ | |
| Polyacrylamide | NP | bovine aortic endothelial cells (BAECs) | Internalization per cell increases at higher stiffness (100 nm carboxylated polystyrene nanoparticles). | [ |
| Polyacrylamide | LPS and TNF-α | Human pulmonary artery endothelial cells (HPAEC) and | ↑ stiffness ↑ response (ICAM1/VCAM1 and fibronectin). | [ |
| Alginate hydrogels | Acetaminophen, Acrylamide, Cadmium chloride, and quinidine | Human U-87 and U-251 glioblastoma, IMR-32 | Cells in | [ |
| Alginate hydrogels ±RGD | Acrylamide and Cadmium | Glioblastoma cells U-87 and U-251 | [ | |
| Polyacrylamide | Gemcitabine and Paclitaxel | Pancreatic cancer cells BxPC-3 and Suit2-007 AsPC-1 cells | Response to nucleoside analogue | [ |
| Polyacrylamide | NP | Breast cancer cell lines | Internalization efficiency increases at higher stiffness’s (pluronic PEG-based micellar nanoparticles). | [ |
Overview of publications describing toxicologically relevant processes in presence of shear stress in endothelial cells. For comparison conversion is provided between cgs unit dyn/cm2 and SI units N/m2, equivalent to Pascal (Pa). 1 dyn/cm2 = 0.1 N/m2 = 0.1 Pa.
| Physical Stimulation | N/m2 | Chemical Stimulation | Response | Reference |
|---|---|---|---|---|
| 6.6–3.3–0.5 N/m2 | 6.6-3.3-0.5 | Mesoporous Silica NP | Shear stress modulate cytotoxic potential. | [ |
| 5 µL/min | 0.01 | Gold Nanoparticles (13±3 nm Ø) | ↑ viability in microfluidic device Live/Dead Assay. | [ |
| 10 dyn 3 h | 1 | Gold Nanoparticles | ↓ AuNPs uptake with shear stress and ↑ anti-ICAM-1 AuNPs uptake with shear stress and TNF-α. | [ |
| 5 µL/min | 0.01 | Gold Nanoparticles (13 ± 3 and 24 ± 8 nm Ø) | ↑ viability in microfluidic device Live/Dead Assay. | [ |
| 0.1-0.2-0.8 Pa | 0.1-0.2-0.8 | Red Fluorophore-loaded carboxylate-capped NP (200 nm Ø) | Uptake dependent on the laminar or disturbed flow. | [ |
| 0.01-0.09 Pa | 0.01-0.09 | Vandetanib 8 µM | Shear stress + Vandetanib induced morphological changes, ROS and apoptosis rate (%). No effect for drugs and shear stress alone. | [ |
| 5 dyn /cm2 | 0.5 | TNF-α 100 U/mL Doxorubicin 1 µM | Shear stress ↓ICAM-1 and VCAM-1 induced by TNF-α. Shear Stress ↑ toxicity of Doxorubicin. | [ |
| 2–12 dyn /cm2 | 0.2-1.2 | TNF-α 0.3 ng/mL | 2-4 dyn /cm2 ↑ VCAM-1; 12 dyn /cm2 ↓VCAM-1 expression induced by TNF-α. | [ |
| 2 dyn /cm2 | 0.2 | Ivabradine 0.04 μM | Ivabradine treatment ↓VCAM-1, IL-6 and ROS induced by shear stress. | [ |
Figure 2(A). Representative experimental layout in static conditions. (B). Representative experimental layout in presence of biomechanical stimulation to mimic specific pathophysiological processes.